SCHEMBL19081709

SCHEMBL19081709

c1ccc2c(c1)ccc1oc3c(ccc4oc5ccc(-c6c7ccccc7c(-c7ccc8c(c7)sc7ccccc78)c7ccccc67)cc5c43)c12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.34
RAB9A P51151 3/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ABCG2 Q9UNQ0 5/20 0.34
NPC1 O15118 3/20 0.34
PAX8 Q06710 2/20 0.34
AHR P35869 2/20 0.34
CYP1A2 P05177 2/20 0.34
NQO1 P15559 1/20 0.34
NQO2 P16083 1/20 0.34
CYP1A1 P04798 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
GPR3 P46089 1/20 0.32
ESR2 Q92731 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944738 0.94 RAB9A (0.38) TDP1RAB9AALDH1A1MAPTHPGD
SCHEMBL19081711 0.91 CYP1A1 (0.35) TDP1RAB9AALDH1A1MAPTHPGD
SCHEMBL23427359 0.91 TDP1 (0.37) TDP1RAB9AALDH1A1MAPTHPGD
SCHEMBL17945653 0.88 MAPT (0.37) RAB9AALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL20127309 0.88 ABCG2 (0.38) TDP1RAB9AMAPTHPGDL3MBTL1
SCHEMBL19081714 0.87 CYP1A1 (0.36) TDP1ALDH1A1MAPTHPGDABCG2
SCHEMBL23428391 0.87 ABCG2 (0.40) TDP1RAB9AALDH1A1MAPTHPGD
SCHEMBL19081721 0.87 RAB9A (0.35) TDP1RAB9AALDH1A1MAPTHPGD
SCHEMBL19081712 0.87 TDP1 (0.35) TDP1RAB9AALDH1A1MAPTHPGD
SCHEMBL23427369 0.87 ABCG2 (0.40) TDP1RAB9AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TDP1 2322/4885RAB9A 3068/4885ALDH1A1 326/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TDP1 2322/4885RAB9A 3068/4885ALDH1A1 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.